Herantis Pharma Plc's financial reporting in 2015
(Thomson Reuters ONE) -
Herantis Pharma Plc's financial reporting in 2015
Herantis Pharma Plc.
Company release 18 December 2014 at 10:00 am
Herantis Pharma will publish the following financial reports in 2015:
* Financial Statements bulletin in regard to 2014 on Friday the 27th of
February 2015
* Interim Report on January-June 2015 on Wednesday the 19th of August 2015
The Annual General Meeting is planned to be held on Thursday the 9th of April
2015. The Board of Directors will present a formal notice of the AGM at a later
stage.
Annual Report for 2014 will be published during the week 13/2015 in electronic
format on the company's web site.
Further information:
Herantis Pharma Plc., Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225
About Herantis Pharma Plc.
Herantis Pharma Plc. is a pharmaceutical company specialised in new drug
research and development. The company focuses on diseases with an unmet clinical
need. These diseases include for example dry eye syndrome, Parkinson's disease,
and secondary lymphedema. We believe our drugs are the first or best in their
class and have the potential to change treatment strategies of diseases. The
shares of Herantis Pharma Plc. are listed on the First North Finland marketplace
run by NASDAQ Helsinki stock exchange.
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Herantis Pharma Oyj via GlobeNewswire
[HUG#1881263]
Unternehmensinformation / Kurzprofil:
Datum: 18.12.2014 - 09:00 Uhr
Sprache: Deutsch
News-ID 360380
Anzahl Zeichen: 2138
contact information:
Town:
Helsinki
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 137 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Herantis Pharma Plc's financial reporting in 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Herantis Pharma Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
